Identifying work behavior that is harmful to health

Measures subfunctions of attention.
These subfunctions measure alertness, vigilance & sustained attention, focused attention, divided attention, selective attention, spatial attention & neglect, smooth pursuit eye movements, and visual scanning.
Long and short forms are available for the subtests which make it possible to measure dimensions of attention under different presentation modalities. There are thus WAF subtests for visual, auditory, or cross-modal test presentations. In some subtests of the WAF test battery automated and controlled (top-down) aspects of attention are also measured separately; the stimuli either become more prominent because the intensity level is increased ("popping out"), or they become less prominent. Both attention processes are relevant in everyday life; both can interact and both can be selectively impaired, for example as a result of brain damage, since they are based on different cerebral networks.
Attention performances are important for the successful handling of the tasks that the individual encounters in daily life. They are not independent of other skills but are a constituent of many processes of perception, memory, planning and acting, spatial orientation and problem-solving. Attention functions are thus basic skills that are required in almost every practical or intellectual activity. Many neurological and psychological disorders and diseases have an adverse effect on different aspects of attention performance. The WAF tests, which are model and guideline compliant (GNP), are therefore used mainly in the context of clinical neuropsychological investigations since they provide both a global and a differentiated assessment of an individual’s strengths and weaknesses. They are also used for personnel selection (especially in the field of manufacturing & safety assessments) and for traffic psychological investigations. 

Assesses the level of clinical anxiety.
This self-assessment tool can be used for the differential assessment of anxiety disorders and sub-clinical anxiety and to differentiate between these and depressive symptoms. It provides useful information for the assessment of therapy indications and the progress of treatment.

Assesses the level of depressive symptoms.
The self-assessment tool BDI-II is used mainly for differential assessment; it is the standard test in the clinical and research field. For clinical neuropsychology patients with a primary diagnosis such as schizophrenia, panic disorder or compulsive disorder it is important from the point of view of treatment to identify depressive components.

Measures the perceived psychological impairment due to physical and mental symptoms of a person within a period of 7 days. SCL-90-R is a multidimensional test which covers the areas of somatization, obsessive-compulsive disorder, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. The main areas of application of the SCL-90-R are the medical, psychological, medical-psychological, psychosocial, psychotherapeutic, and psychiatric sector.

Measurement of general cognitive ability based on logical reasoning with a focus on the lower performance range. The simply designed item material is easy to recognize visually and can therefore be presented up to an old age. In addition, the test can be carried out on mobile devices or with supervisor-supported instruction, if needed.

Therefore, the test is suitable for application in the following areas: clinical psychology and neuropschology, human resources, particularly in the safety & security area as well as for occupational and organizational psychology assessment situations, in the education area and special fields of psychological assessment such as assessment of fitness to drive.